- Home
- MOLN vs SJT Comparison
MOLN vs SJT Comparison
Compare MOLN & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- SJT
- Stock Information
- Founded
- MOLN 2004
- SJT 1980
- Country
- MOLN Switzerland
- SJT United States
- Employees
- MOLN N/A
- SJT N/A
- Industry
- MOLN
- SJT Oil & Gas Production
- Sector
- MOLN
- SJT Energy
- Exchange
- MOLN Nasdaq
- SJT Nasdaq
- Market Cap
- MOLN 183.2M
- SJT 281.5M
- IPO Year
- MOLN 2021
- SJT N/A
- Fundamental
- Price
- MOLN $3.89
- SJT $5.99
- Analyst Decision
- MOLN
- SJT
- Analyst Count
- MOLN 0
- SJT 0
- Target Price
- MOLN N/A
- SJT N/A
- AVG Volume (30 Days)
- MOLN 2.4K
- SJT 231.2K
- Earning Date
- MOLN 08-25-2025
- SJT 08-13-2025
- Dividend Yield
- MOLN N/A
- SJT N/A
- EPS Growth
- MOLN N/A
- SJT N/A
- EPS
- MOLN N/A
- SJT 0.02
- Revenue
- MOLN $2,525,030.00
- SJT $1,931,777.00
- Revenue This Year
- MOLN N/A
- SJT N/A
- Revenue Next Year
- MOLN $866.67
- SJT N/A
- P/E Ratio
- MOLN N/A
- SJT $254.11
- Revenue Growth
- MOLN N/A
- SJT N/A
- 52 Week Low
- MOLN $3.36
- SJT $3.21
- 52 Week High
- MOLN $12.22
- SJT $7.22
- Technical
- Relative Strength Index (RSI)
- MOLN 43.53
- SJT 40.38
- Support Level
- MOLN $3.50
- SJT $6.28
- Resistance Level
- MOLN $3.90
- SJT $7.00
- Average True Range (ATR)
- MOLN 0.17
- SJT 0.29
- MACD
- MOLN -0.01
- SJT -0.10
- Stochastic Oscillator
- MOLN 12.70
- SJT 16.78
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.